TGF-β is upregulated in human and experimental kidney disease and is a central player in development of kidney fibrosis; therefore, we examined if signaling from PAR2 transactivates the TβRI-Smad pathway in our HTEC culture model. Here, TGFBR1 is linked to kidney disorder.